Procedure: hydrocortisone withdrawal (DrugBank: Hydrocortisone)
9 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
6 | Parkinson disease | 0 |
46 | Malignant rheumatoid arthritis | 0 |
53 | Sjogren syndrome | 0 |
75 | Cushing disease | 0 |
78 | Hypopituitarism | 0 |
81 | Congenital adrenal hyperplasia | 1 |
83 | Addison disease | 0 |
97 | Ulcerative colitis | 0 |
299 | Cystic fibrosis | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00542841 (ClinicalTrials.gov) | August 2007 | 10/10/2007 | Examining Genetic Differences Among People With 21-Hydroxylase Deficiency | Modifier Genes in 21-Hydroxylase Deficiency | 21-hydroxylase Deficiency | Procedure: Hydrocortisone withdrawal | Maria I. New | Office of Rare Diseases (ORD);National Center for Research Resources (NCRR) | Completed | 18 Years | 50 Years | Both | 99 | N/A | United States;Brazil;France |